Signaturefd, LLC Fibrogen Inc Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$15.95 - $25.18 $1,770 - $2,794	111 Added 116.84%	206 $3,000
Q4 2022 Jan 27, 2023	BUY	$13.27 - $17.73 $384 - $514	29 Added 43.94%	95 $1,000
Q3 2022 Nov 08, 2022	BUY	$11.4 - $14.6 $752 - $963	66 New	66 $1,000
Q2 2022 Aug 10, 2022	SELL	$7.94 - $12.96 $762 - $1,244	-96 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$12.02 - $16.79 $1,153 - $1,611	96 New	96 $1,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.